CL2018003514A1 - Péptidos para la inhibición de infecciones causadas por un parásito. - Google Patents

Péptidos para la inhibición de infecciones causadas por un parásito.

Info

Publication number
CL2018003514A1
CL2018003514A1 CL2018003514A CL2018003514A CL2018003514A1 CL 2018003514 A1 CL2018003514 A1 CL 2018003514A1 CL 2018003514 A CL2018003514 A CL 2018003514A CL 2018003514 A CL2018003514 A CL 2018003514A CL 2018003514 A1 CL2018003514 A1 CL 2018003514A1
Authority
CL
Chile
Prior art keywords
peptides
inhibition
parasite
infections caused
compositions
Prior art date
Application number
CL2018003514A
Other languages
English (en)
Inventor
Scott Mckinley
Original Assignee
Aqua Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO20160995A external-priority patent/NO345090B1/no
Priority claimed from NO20162073A external-priority patent/NO343281B1/en
Application filed by Aqua Health As filed Critical Aqua Health As
Publication of CL2018003514A1 publication Critical patent/CL2018003514A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Insects & Arthropods (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE DESCRIPCIÓN TRATA DE PÉPTIDOS QUE INHIBEN LA TRIPSINA. TAMBIÉN SE DESCRIBEN COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN DICHOS PÉPTIDOS, Y EL USO DE DICHOS PÉPTIDOS Y COMPOSICIONES FARMACÉUTICAS PARA LA INHIBICIÓN DE INFESTACIÓN POR PIOJOS Y PARA LA PREVENCIÓN O EL TRATAMIENTO DE INFECCIONES EN SALMÓNIDOS CAUSADOS POR PIOJOS DE MAR.
CL2018003514A 2016-06-10 2018-12-07 Péptidos para la inhibición de infecciones causadas por un parásito. CL2018003514A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20160995A NO345090B1 (en) 2016-06-10 2016-06-10 Peptides for the inhibition of trypsin and sea lice infestation
NO20162073A NO343281B1 (en) 2016-12-30 2016-12-30 Peptides for the inhibition of trypsin and sea lice infestation.
NO20170778A NO343723B1 (en) 2016-06-10 2017-05-11 Peptides for the inhibition of trypsin and sea lice infestation.

Publications (1)

Publication Number Publication Date
CL2018003514A1 true CL2018003514A1 (es) 2019-05-03

Family

ID=61827448

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2018003514A CL2018003514A1 (es) 2016-06-10 2018-12-07 Péptidos para la inhibición de infecciones causadas por un parásito.
CL2018003513A CL2018003513A1 (es) 2016-06-10 2018-12-07 Péptidos para la inhibición de la tripsina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CL2018003513A CL2018003513A1 (es) 2016-06-10 2018-12-07 Péptidos para la inhibición de la tripsina.

Country Status (5)

Country Link
EP (3) EP3468988B1 (es)
CA (2) CA3026200C (es)
CL (2) CL2018003514A1 (es)
DK (4) DK3468988T5 (es)
NO (1) NO343723B1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825854D0 (en) * 1998-11-25 1999-01-20 Univ Bristol Peptide
EP2397552A1 (en) * 2004-07-28 2011-12-21 National Research Council Of Canada Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
CU23919B1 (es) * 2010-09-28 2013-07-31 Ct De Ingeniería Genética Y Biotecnología Composición vacunal para el control de las infestaciones por ectoparásitos
GB2522119A (en) * 2012-05-17 2015-07-15 Tecnovax Chile S A Peptides inducing an immune response against copepods and/or the development of a mucous shield in fish

Also Published As

Publication number Publication date
DK180659B1 (en) 2021-11-11
NO343723B1 (en) 2019-05-20
DK3468988T3 (da) 2024-04-29
CA3026200A1 (en) 2017-12-14
EP3468988A1 (en) 2019-04-17
DK201870824A1 (en) 2019-02-01
EP3468989A1 (en) 2019-04-17
CA3026200C (en) 2023-06-27
NO20170778A1 (en) 2017-12-11
EP3795589A1 (en) 2021-03-24
CL2018003513A1 (es) 2019-05-03
DK3468988T5 (da) 2024-09-09
DK180277B1 (en) 2020-09-25
DK201870818A1 (en) 2019-04-16
DK3468989T3 (en) 2023-08-21
EP3468989B1 (en) 2023-06-07
CA3026210A1 (en) 2017-12-14
EP3468988B1 (en) 2024-01-31

Similar Documents

Publication Publication Date Title
CO2018010459A2 (es) Composiciones que comprenden cepas bacterianas
CL2018001358A1 (es) Composiciones que comprenden cepas bacterianas
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001368A1 (es) Composiciones que comprenden cepas bacterianas
ECSP19015192A (es) Composiciones y métodos de inhibir masp-3 para el tratamiento de diversas enfermedades y trastornos
CL2019000694A1 (es) Un complejo novedoso que comprende un péptido penetrante de células, una carga y un agonista de péptido de tlr para tratamiento de cáncer colorrectal.
CL2018000978A1 (es) Macrociclos peptídicos contra acinetobacter baumannii
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
MX2020011104A (es) Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso.
MX369041B (es) Proteinas quimericas tipo fosfatasa alcalina.
MX364942B (es) Peptidos antimicrobianos.
BR112016018062A8 (pt) compostos terapêuticos, composição farmacêutica e usos
GT201700124A (es) Formulación de relación fija de insulina glargina/lixisenatida
MX2019006852A (es) Composiciones y metodos para modular el sistema inmunologico.
MX2017007595A (es) Inmunoterapia para enfermedad angiogenica.
MX2017009849A (es) Composiciones de profármaco de monometilfumarato.
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
ECSP17074919A (es) Piroglutamato de vortioxetina
CL2017000178A1 (es) Compuestos para usar en el tratamiento antihelmíntico
MX2019012522A (es) Compuestos y metodos terapeuticos.
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
CL2016001977A1 (es) Composición que comprende igm derivada de plasma y su uso para el tratamiento o prevención de afecciones inmunitarias.